H-Index
34
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST

Logo

MSMbanner
Medical Science Monitor Basic Research

AmJCaseRep
MedSciTechnol

eISSN: 2329-0358

Processings, storage and experimental transplantation of human fetal pancreatic cells

Alberto Hayek, Gillian M Beattie

Ann Transplant 1997; 2(3): 46-54

ID: 497172

Available online: 1997-09-12

Published: 1997-09-12


Almost 25 years ago following reports of successful shortterm culture of the human fetal pancreas, it was suggested that fetal pancreatic cells could be used as a cell-based insulin delivery system in insulin-dependent diabetes (IDDM) [1]. Several trials using fetal pancreatic explants in transplantation procedures to patients with IDDM were undertaken mostly in Eastern European countries and China (reviewed in [2]). However, the results of those trials could not be analyzed because the information reported was insufficient to draw valid conclusions. Limited clinical trials in Australia [3] and the U.S. [2] indicated that the tissue was antigenic and that it could survive after transplantation under the kidney capsule in immunosuppressed patients who had received a kidney transplant.

Keywords: human fetal pancreatic tissue, proliferation, differentiation, Transplantation



Back